|
CST3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
2.69220000004289E-06 |
| Normal-vs-Stage3 |
1.60639999999823E-05 |
| Normal-vs-Stage4 |
3.424100E-02 |
| Stage1-vs-Stage2 |
1.747240E-01 |
| Stage1-vs-Stage3 |
6.681900E-03 |
| Stage1-vs-Stage4 |
1.798080E-04 |
| Stage2-vs-Stage3 |
2.785200E-01 |
| Stage2-vs-Stage4 |
1.433960E-02 |
| Stage3-vs-Stage4 |
8.863600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.62590000246854E-08 |
| Normal-vs-Asian |
4.57529999997597E-07 |
| Caucasian-vs-AfricanAmerican |
7.207000E-01 |
| Caucasian-vs-Asian |
9.844400E-01 |
| AfricanAmerican-vs-Asian |
9.235200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
2.49570000221411E-08 |
| Male-vs-Female |
2.271200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.049660E-04 |
| Normal-vs-Extreme_Weight |
4.39648317751562E-14 |
| Normal-vs-Obese |
5.36829469766076E-11 |
| Normal-vs-Extreme_Obese |
8.319600E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.638400E-01 |
| Normal_Weight-vs-Obese |
9.829600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.602400E-01 |
| Extreme_Weight-vs-Obese |
4.096200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.565390E-01 |
| Obese-vs-Extreme_Obese |
2.631400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.354670E-04 |
| Normal-vs-Age(41-60Yrs) |
2.47124543051314E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
1.999750E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.834800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.393400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.889200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.435600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.056200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.751400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.06680000000015E-05 |
| Normal-VS-KIRP CIMP |
4.275100E-03 |
| Normal-VS-Unclassified PRCC |
2.04979999995913E-06 |
| Type1 PRCC-VS-Type2 PRCC |
5.212400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.045600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.790400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.620800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.516400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.531800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.61060001288871E-09 |
| Normal-vs-N1 |
8.355600E-04 |
| Normal-vs-N2 |
7.851000E-01 |
| N0-vs-N1 |
1.022230E-01 |
| N0-vs-N2 |
4.010300E-02 |
| N1-vs-N2 |
9.931700E-02 |
|
|
